These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8566940)

  • 1. A meta-analysis of randomized, double-blind, placebo-controlled studies of the effect of buflomedil on intermittent claudication.
    Walker GA; Mac Hannaford JC
    Fundam Clin Pharmacol; 1995; 9(4):387-94. PubMed ID: 8566940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buflomedil for intermittent claudication.
    De Backer TL; Vander Stichele RH; Bogaert MG
    Cochrane Database Syst Rev; 2001; (1):CD000988. PubMed ID: 11279700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buflomedil for intermittent claudication.
    de Backer TL; Bogaert M; Vander Stichele R
    Cochrane Database Syst Rev; 2007 Oct; (4):CD000988. PubMed ID: 17943749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buflomedil for intermittent claudication.
    de Backer TL; Bogaert M; Vander Stichele R
    Cochrane Database Syst Rev; 2008 Jan; (1):CD000988. PubMed ID: 18253982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buflomedil for intermittent claudication.
    de Backer TL; Vander Stichele R
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD000988. PubMed ID: 23543509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ; Grigoriadou M; Ifanti G; Raptis SA
    Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
    Beebe HG; Dawson DL; Cutler BS; Herd JA; Strandness DE; Bortey EB; Forbes WP
    Arch Intern Med; 1999 Sep; 159(17):2041-50. PubMed ID: 10510990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G; Balzer K; Bisler H; Klüken N; Muller-Wiefel H; Unkel B; Mahfoud Y; Ziegler W
    Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
    Van den Brande P; Maurel A
    Angiology; 1998 Feb; 49(2):105-14. PubMed ID: 9482510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline for intermittent claudication.
    Salhiyyah K; Forster R; Senanayake E; Abdel-Hadi M; Booth A; Michaels JA
    Cochrane Database Syst Rev; 2015 Sep; 9(9):CD005262. PubMed ID: 26417854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V; Mikhailidis DP; Barradas MA; Jeremy JY; Gracey L; Dandona P
    Int J Clin Pharmacol Res; 1988; 8(5):377-81. PubMed ID: 3229875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    ; Leizorovicz A; Becker F
    Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
    Peters H; Kieser M; Hölscher U
    Vasa; 1998 May; 27(2):106-10. PubMed ID: 9612115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of long-term safety data with buflomedil.
    Bachand RT; Dubourg AY
    J Int Med Res; 1990; 18(3):245-52. PubMed ID: 2193838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
    Money SR; Herd JA; Isaacsohn JL; Davidson M; Cutler B; Heckman J; Forbes WP
    J Vasc Surg; 1998 Feb; 27(2):267-74; discussion 274-5. PubMed ID: 9510281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.
    Dawson DL; Cutler BS; Meissner MH; Strandness DE
    Circulation; 1998 Aug; 98(7):678-86. PubMed ID: 9715861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs.
    Chacón-Quevedo A; Eguaras MG; Calleja F; Garcia MA; Roman M; Casares J; Muñoz I; Concha M
    Angiology; 1994 Jul; 45(7):647-53. PubMed ID: 8024164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies.
    Momsen AH; Jensen MB; Norager CB; Madsen MR; Vestersgaard-Andersen T; Lindholt JS
    Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):463-74. PubMed ID: 19586783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cloricromene on intermittent claudication. A randomized, double-blind, placebo-controlled trial in patients treated with aspirin: effect on claudication distance and quality of life. CRAMPS Investigator Group. Cloricromene Randomized Arteriopathy Multicenter Prospective Study.
    Gresele P; Migliacci R; Di Sante G; Nenci GG;
    Vasc Med; 2000; 5(2):83-9. PubMed ID: 10943584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
    Diehm C; Eckstein M; Hübsch-Müller C
    Vasa; 1989; 18(1):40-7. PubMed ID: 2648691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.